Category: Uncategorized

Jun 18 2026

Uncategorized

How early life experiences shape schizophrenia risk

by Clinical Editor

No Comments

Carnegie Mellon University and University of California, San Francisco researchers have found that childhood trauma, poverty, social isolation and other adverse life experiences are associated with …

Jun 18 2026

Uncategorized

Adverse life experiences alter brain structure linked to schizophrenia

by Clinical Editor

No Comments

Carnegie Mellon University and University of California, San Francisco researchers found that childhood trauma, poverty, social isolation and other adverse life experiences are associated with brain …

Jun 17 2026

Uncategorized

Choosing the Right Formulation in Schizophrenia Treatment – Psychiatric Times

by Clinical Editor

No Comments

Choosing the Right Formulation in Schizophrenia Treatment  Psychiatric Times

Jun 17 2026

Uncategorized

Decision processes in 3D structural MRI schizophrenia classification evaluated with saliency maps – Nature

by Clinical Editor

No Comments

Decision processes in 3D structural MRI schizophrenia classification evaluated with saliency maps  Nature

Jun 16 2026

Uncategorized

Distinct contributions of schizophrenia and neurotransmitter pathway genetic liability to neurocognition and antipsychotic efficacy in drug-naïve first-episode schizophrenia – Nature

by Clinical Editor

No Comments

Distinct contributions of schizophrenia and neurotransmitter pathway genetic liability to neurocognition and antipsychotic efficacy in drug-naïve first-episode schizophrenia  Nature

Jun 16 2026

Uncategorized

Schizophrenia – American Academy of Family Physicians | AAFP

by Clinical Editor

No Comments

Schizophrenia  American Academy of Family Physicians | AAFP

Jun 13 2026

Uncategorized

Consensus on Overcoming Barriers to Long-Acting Injectable Use in Schizophrenia – Psychiatric Times

by Clinical Editor

No Comments

Consensus on Overcoming Barriers to Long-Acting Injectable Use in Schizophrenia  Psychiatric Times

Jun 13 2026

Uncategorized

Lumateperone Linked to Lower Risk for Schizophrenia Relapse – Medscape

by Clinical Editor

No Comments

Lumateperone Linked to Lower Risk for Schizophrenia Relapse  Medscape

Jun 13 2026

Uncategorized

Is Cannabis Psychosis Riskier Than Drug-Induced Psychosis?

by Clinical Editor

No Comments

Researchers recently found cannabis can trigger psychosis that may be different from schizophrenia or could be similar. Ending or decreasing cannabis use may improve the condition.

Jun 12 2026

Uncategorized

Social Determinants of Health and Long-Term Engagement in Schizophrenia Care – Psychiatric Times

by Clinical Editor

No Comments

Social Determinants of Health and Long-Term Engagement in Schizophrenia Care  Psychiatric Times